These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 2142293

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of Atrovent administered by inhalation on pulmonary mechanics in patients with obstructive lung disease [proceedings].
    Koch G.
    Scand J Respir Dis Suppl; 1979; 103():206-7. PubMed ID: 155300
    [No Abstract] [Full Text] [Related]

  • 24. [Role of anticholinergic agents in the treatment of cystic fibrosis].
    Sanchez I.
    Arch Pediatr; 1995; 2 Suppl 2():154S-158S. PubMed ID: 7633556
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of nebulized ipratropium bromide on lung function in nonallergic bronchial asthma.
    Wegener T, Hedenström H.
    Respiration; 1987; 52(1):1-6. PubMed ID: 2958914
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline.
    Adams C, Icheva V, Deppisch C, Lauer J, Herrmann G, Graepler-Mainka U, Heyder S, Gulbins E, Riethmueller J.
    Cell Physiol Biochem; 2016; 39(2):565-72. PubMed ID: 27395380
    [Abstract] [Full Text] [Related]

  • 29. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis.
    Ratjen F, Gärtig S, Wiesemann HG, Grasemann H.
    Respir Med; 1999 Aug; 93(8):579-83. PubMed ID: 10542992
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis.
    White H, Shaw N, Denman S, Pollard K, Wynne S, Peckham DG.
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28275171
    [Abstract] [Full Text] [Related]

  • 36. Variability of pulmonary function tests in cystic fibrosis.
    Cooper PJ, Robertson CF, Hudson IL, Phelan PD.
    Pediatr Pulmonol; 1990 Mar; 8(1):16-22. PubMed ID: 2405342
    [Abstract] [Full Text] [Related]

  • 37. Inhaled mannitol (Bronchitol) for cystic fibrosis.
    Med Lett Drugs Ther; 2021 May 31; 63(1625):85-86. PubMed ID: 34101719
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Question 3: Inhaled mannitol improves lung function in patients with cystic fibrosis.
    Winckworth LC, Holme H.
    Arch Dis Child; 2012 Nov 31; 97(11):1003-6. PubMed ID: 23100616
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.